132 related articles for article (PubMed ID: 8577931)
1. PreproPACAP-derived peptides occur in VIP-producing tumours and co-exist with VIP.
Fahrenkrug J; Buhl T; Hannibal J
Regul Pept; 1995 Aug; 58(3):89-98. PubMed ID: 8577931
[TBL] [Abstract][Full Text] [Related]
2. Comparison between vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide levels in neuroblastoma tumour tissues.
Vertongen P; De Clerck P; Fournet JC; Martelli H; Hélardot P; Devalck C; Peeters T; Sariban E; Robberecht P
Neuropeptides; 1997 Oct; 31(5):409-13. PubMed ID: 9413016
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenylate cyclase activating peptide-38 (PACAP-38), PACAP-27, and PACAP related peptide (PRP) in the rat median eminence and pituitary.
Mikkelsen JD; Hannibal J; Fahrenkrug J; Larsen PJ; Olcese J; McArdle C
J Neuroendocrinol; 1995 Jan; 7(1):47-55. PubMed ID: 7735297
[TBL] [Abstract][Full Text] [Related]
4. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
[TBL] [Abstract][Full Text] [Related]
6. PreproVIP-derived peptides in tissue and plasma from patients with VIP-producing tumours.
Rønnov-Jensen D; Gether U; Fahrenkrug J
Eur J Clin Invest; 1991 Apr; 21(2):154-60. PubMed ID: 1647952
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenylate cyclase activating polypeptide (PACAP)-like immunoreactivity in pheochromocytomas.
Takahashi K; Totsune K; Murakami O; Sone M; Itoi K; Miura Y; Mouri T
Peptides; 1993; 14(2):365-9. PubMed ID: 8483815
[TBL] [Abstract][Full Text] [Related]
8. Pituitary adenylate cyclase activating polypeptide innervation of the rat female reproductive tract and the associated paracervical ganglia: effect of capsaicin.
Fahrenkrug J; Hannibal J
Neuroscience; 1996 Aug; 73(4):1049-60. PubMed ID: 8809823
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid regulation of the VIP and PACAP autocrine ligand and receptor system in human neuroblastoma cell lines.
Waschek JA; Lelievre V; Bravo DT; Nguyen T; Muller JM
Peptides; 1997; 18(6):835-41. PubMed ID: 9285932
[TBL] [Abstract][Full Text] [Related]
10. VIP and PACAP.
Fahrenkrug J
Results Probl Cell Differ; 2010; 50():221-34. PubMed ID: 19859678
[TBL] [Abstract][Full Text] [Related]
11. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenylate cyclase activating polypeptide (PACAP) in the gastrointestinal tract of the rat: distribution and effects of capsaicin or denervation.
Hannibal J; Ekblad E; Mulder H; Sundler F; Fahrenkrug J
Cell Tissue Res; 1998 Jan; 291(1):65-79. PubMed ID: 9394044
[TBL] [Abstract][Full Text] [Related]
13. Pituitary adenylate cyclase activating polypeptide immunoreactivity in capsaicin-sensitive nerve fibres supplying the rat urinary tract.
Fahrenkrug J; Hannibal J
Neuroscience; 1998 Apr; 83(4):1261-72. PubMed ID: 9502264
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenylate cyclase activating peptide and its receptors are expressed in human neuroblastomas.
Vertongen P; Devalck C; Sariban E; De Laet MH; Martelli H; Paraf F; Hélardot P; Robberecht P
J Cell Physiol; 1996 Apr; 167(1):36-46. PubMed ID: 8698838
[TBL] [Abstract][Full Text] [Related]
15. Structural requirements for the binding of the pituitary adenylate-cyclase-activating peptide to receptors and adenylate-cyclase activation in pancreatic and neuronal membranes.
Gourlet P; Woussen-Colle MC; Robberecht P; de Neef P; Cauvin A; Vandermeers-Piret MC; Vandermeers A; Christophe J
Eur J Biochem; 1991 Jan; 195(2):535-41. PubMed ID: 1997328
[TBL] [Abstract][Full Text] [Related]
16. Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain.
Köves K; Arimura A; Görcs TG; Somogyvári-Vigh A
Neuroendocrinology; 1991 Aug; 54(2):159-69. PubMed ID: 1766552
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adelylate cyclase-activating peptide is an activator of vasoactive intestinal polypeptide gene transcription in human neuroblastoma cells.
Georg B; Fahrenkrug J
Brain Res Mol Brain Res; 2000 Jun; 79(1-2):67-76. PubMed ID: 10925144
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum.
Hedlund P; Alm P; Ekström P; Fahrenkrug J; Hannibal J; Hedlund H; Larsson B; Andersson KE
Br J Pharmacol; 1995 Oct; 116(4):2258-66. PubMed ID: 8564257
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenylate cyclase-activating polypeptide does not colocalize with vasoactive intestinal polypeptide in the hypothalamic magnocellular nuclei and posterior pituitary of cats and rats.
Vereczki V; Köves K; Tóth ZE; Baba A; Hashimoto H; Fógel K; Arimura A; Kausz M
Endocrine; 2003 Dec; 22(3):225-37. PubMed ID: 14709795
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
